Britain and France strike landmark AI pact to transform women's health and tackle drug-resistant superbugs

A UK-France science and technology partnership will use artificial intelligence and shared clinical data to advance research in women’s health and infectious diseases. The plan targets conditions that have been under-researched and under-diagnosed, aiming to reduce long waits for answers by pooling datasets and clinical expertise. Expected outcomes include earlier diagnoses, safer pregnancies, and more personalised care. The partnership also supports broader goals around AI adoption and online child safety through cross-Channel cooperation. In infectious disease work, advanced imaging and AI will be applied to improve understanding and responses to infections, including drug-resistant threats. The agreement is intended to strengthen cross-border funding, talent exchange, and commercial opportunities for life sciences companies.

"The agreement, light on diplomatic gloss and heavy on practical intent, places artificial intelligence and shared clinical data at the heart of a joint push into two areas that have long been the Cinderellas of medical research: women's health and infectious disease. For an SME-rich life sciences sector on both sides of the Channel, it also reopens a more reliable pipeline of cross-border funding, talent and commercial opportunity at a moment when post-Brexit research ties have been quietly knitting back together."

"Officials say the partnership will accelerate work on conditions that have been systematically under-researched and under-diagnosed, with patients on both sides of the Channel waiting years for answers. By pooling datasets and clinical expertise, British and French researchers expect to deliver earlier diagnoses, safer pregnancies and more personalised care. As the Women's Organisation has previously warned in Business Matters , more than a third of women feel unsupported on issues such as endometriosis, fertility and menopause, with measurable knock-on effects on productivity, promotion and pay across the SME workforce."

"Kendall, who took on the science and technology brief last September, said the deal would "tackle some of the biggest challenges in women's health, deliver safer and healthier pregnancies, and accelerate the fight against infectious diseases worldwide". She added that the spirit of cross-Channel co-operation would carry into wider G7 discussions on AI adoption and online child safety."

"The agreement also turns the firepower of cutting-edge imaging and AI on infectious diseases, with rese"

Read at Business Matters